Log in to save to my catalogue

High Response Rates and Prolonged Survival in Patients With Corticotroph Pituitary Tumors and Refrac...

High Response Rates and Prolonged Survival in Patients With Corticotroph Pituitary Tumors and Refrac...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1508946548

High Response Rates and Prolonged Survival in Patients With Corticotroph Pituitary Tumors and Refractory Cushing Disease From Capecitabine and Temozolomide (CAPTEM): A Case Series

About this item

Full title

High Response Rates and Prolonged Survival in Patients With Corticotroph Pituitary Tumors and Refractory Cushing Disease From Capecitabine and Temozolomide (CAPTEM): A Case Series

Publisher

United States: Copyright by the Congress of Neurological Surgeons

Journal title

Neurosurgery, 2014-04, Vol.74 (4), p.E447-E455

Language

English

Formats

Publication information

Publisher

United States: Copyright by the Congress of Neurological Surgeons

More information

Scope and Contents

Contents

BACKGROUND AND IMPORTANCE:Rarely, corticotrophic pituitary tumors take on an aggressive form characterized by rapid growth, invasion into local structures, compression of cranial nerves, and possible spread to distant sites. When conventional surgery, radiation therapy, and hormones fail to control progression and symptoms, alternative therapies ar...

Alternative Titles

Full title

High Response Rates and Prolonged Survival in Patients With Corticotroph Pituitary Tumors and Refractory Cushing Disease From Capecitabine and Temozolomide (CAPTEM): A Case Series

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1508946548

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1508946548

Other Identifiers

ISSN

0148-396X

E-ISSN

1524-4040

DOI

10.1227/NEU.0000000000000251

How to access this item